Numerous agents targeting various phosphatidylinositol 3-kinase (PI3K) pathway components, including PI3K, AKT and mTOR, have been tested in oncology clinical trials, resulting in regulatory approvals ...
CECs are present in the outermost layer of the cornea and play an important role in maintaining CE homeostasis and optical function. The PI3K/AKT signalling pathway is widely involved in the ...
Experts in cell signaling at the Babraham Institute have identified how prostate cancer cells achieve cell growth free from the usual growth cues and regulators. This discovery has implications for ...
Low-dose aspirin significantly reduced colorectal cancer recurrence in patients with PI3K pathway gene alterations, nearly halving recurrence rates over three years compared to placebo. The study ...
"Our finding that the PI3K/Akt pathway is anchored on p53 in the nucleus was entirely unexpected," says Cryns, a physician-scientist and professor at UW School of Medicine and Public Health. The ...
Serial cell-free DNA (cfDNA) sampling in advanced pancreatic ductal adenocarcinoma (PDAC) patients may predict therapeutic outcome. This is an ASCO Meeting Abstract from the 2021 Gastrointestinal ...
Measuring PD-L1 mRNA expression using targeted next generation sequencing and correlation with interferon pathway activation genes in lung and colorectal cancers. This is an ASCO Meeting Abstract from ...
The FDA approved the PI3K-pathway inhibitor inavolisib (Itovebi) for use in combination with palbociclib (Ibrance) and fulvestrant to treat locally advanced, PIK3CA ...
Significantly lower incidence of colorectal cancer recurrence seen for patients with somatic alterations in PI3K pathway genes. HealthDay News — Aspirin is associated with a lower incidence of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results